136 related articles for article (PubMed ID: 19474736)
1. Early suspension of activated protein C treatment in septic patients after shock reversal.
Pestaña D; Ramos R
Eur J Anaesthesiol; 2009 Dec; 26(12):1072-5. PubMed ID: 19474736
[TBL] [Abstract][Full Text] [Related]
2. Activated protein C and hospital mortality in septic shock: a propensity-matched analysis.
Lindenauer PK; Rothberg MB; Nathanson BH; Pekow PS; Steingrub JS
Crit Care Med; 2010 Apr; 38(4):1101-7. PubMed ID: 20154607
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
[TBL] [Abstract][Full Text] [Related]
4. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
[TBL] [Abstract][Full Text] [Related]
5. The current management of septic shock.
Russel JA
Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
[TBL] [Abstract][Full Text] [Related]
6. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
de Kleijn ED; de Groot R; Hack CE; Mulder PG; Engl W; Moritz B; Joosten KF; Hazelzet JA
Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
[TBL] [Abstract][Full Text] [Related]
7. Terlipressin facilitates transport of septic patients treated with norepinephrine.
Klein M; Weksler N; Borer A; Koyfman L; Kesslin J; Gurman GM
Isr Med Assoc J; 2006 Oct; 8(10):691-3. PubMed ID: 17125115
[TBL] [Abstract][Full Text] [Related]
8. Implementation of a norepinephrine-based protocol for management of septic shock: a pilot feasibility study.
Hernandez G; Bruhn A; Romero C; Larrondo FJ; De La Fuente R; Cornejo R; Castillo L; Bugedo G
J Trauma; 2006 Jan; 60(1):77-81. PubMed ID: 16456439
[TBL] [Abstract][Full Text] [Related]
9. Before-after study of a standardized hospital order set for the management of septic shock.
Micek ST; Roubinian N; Heuring T; Bode M; Williams J; Harrison C; Murphy T; Prentice D; Ruoff BE; Kollef MH
Crit Care Med; 2006 Nov; 34(11):2707-13. PubMed ID: 16943733
[TBL] [Abstract][Full Text] [Related]
10. [The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock].
Hu B; Li JG; Liang H; Zhou Q; Yu Z; Li L; Luo Y; Liu C; Gan Q
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Sep; 21(9):529-31. PubMed ID: 19751560
[TBL] [Abstract][Full Text] [Related]
11. The outcome of patients with sepsis and septic shock presenting to emergency departments in Australia and New Zealand.
;
Crit Care Resusc; 2007 Mar; 9(1):8-18. PubMed ID: 17352661
[TBL] [Abstract][Full Text] [Related]
12. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
Bauer SR; Lam SW; Cha SS; Oyen LJ
J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of recombinant human activated protein C in a ewe model of septic shock.
Wang Z; Su F; Rogiers P; Vincent JL
Crit Care Med; 2007 Nov; 35(11):2594-600. PubMed ID: 17901839
[TBL] [Abstract][Full Text] [Related]
14. Baseline cortisol levels, total proteins, and eosinophil count as predictors of hemodynamic response to steroid treatment in septic shock.
Pestaña D; Martinez-Casanova E; Buño A; Madero R; Criado A;
J Trauma; 2009 Apr; 66(4):1060-4. PubMed ID: 19359915
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole improves survival in septic shock: a randomized double-blind prospective study.
Jacobs S; Price Evans DA; Tariq M; Al Omar NF
Crit Care Med; 2003 Jul; 31(7):1938-46. PubMed ID: 12847386
[TBL] [Abstract][Full Text] [Related]
16. Early intravenous unfractionated heparin and mortality in septic shock.
Zarychanski R; Doucette S; Fergusson D; Roberts D; Houston DS; Sharma S; Gulati H; Kumar A
Crit Care Med; 2008 Nov; 36(11):2973-9. PubMed ID: 18824906
[TBL] [Abstract][Full Text] [Related]
17. Effects of continuous vasopressin infusion in patients with septic shock.
Obritsch MD; Jung R; Fish DN; MacLaren R
Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of recombinant human activated protein C in patients with septic shock.
Sanchez B; Piacentini E; Pradella V; Mignini M; Nava J
J Crit Care; 2010 Jun; 25(2):343-7. PubMed ID: 19781904
[TBL] [Abstract][Full Text] [Related]
19. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
[TBL] [Abstract][Full Text] [Related]
20. Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.
Lupei MI; Beilman GJ; Chipman JG; Mann HJ
Chirurgia (Bucur); 2009; 104(5):575-81. PubMed ID: 19943557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
